Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lipsitch

Showing results (21-30 of 446) with videos related to

Pageof 45
Sort By:
BMC Infectious Diseases|February 24, 2020
The relation between prescribing of different antibiotics and rates of mortality with sepsis in US adultsEdward Goldstein, Marc Lipsitch
Current Topics in Microbiology and Immunology|July 12, 2019
Enhancing Situational Awareness to Prevent Infectious Disease Outbreaks from Becoming CatastrophicMarc Lipsitch, Mauricio Santillana
Interface Focus|September 29, 2025
Equity considerations in COVID-19 vaccine allocation modelling: a methodological studyEva Rumpler, Marc Lipsitch
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposureNir Eyal, Marc Lipsitch
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2021
How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is AvailableNir Eyal, Marc Lipsitch
Science (New York, N.Y.)|March 3, 2012
Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypesSarah Cobey, Marc Lipsitch
Epidemiology (Cambridge, Mass.)|June 17, 2008
Too little of a good thing: a paradox of moderate infection controlTed Cohen, Marc Lipsitch
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2020
Opinion: It's ethical to test promising coronavirus vaccines against less-promising onesNir Eyal, Marc Lipsitch
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2025
Focusing a viral risk ranking tool on predictionKatherine Budeski, Marc Lipsitch
NEJM Evidence|May 30, 2024
Diagnostics for Public Health - Infectious Disease Surveillance and ControlMarc Lipsitch, Yonatan Grad
Pageof 45

Showing results (21-30 of 446) with videos related to

Sort By:
Pageof 45
BMC Infectious Diseases|February 24, 2020
The relation between prescribing of different antibiotics and rates of mortality with sepsis in US adultsEdward Goldstein, Marc Lipsitch
Current Topics in Microbiology and Immunology|July 12, 2019
Enhancing Situational Awareness to Prevent Infectious Disease Outbreaks from Becoming CatastrophicMarc Lipsitch, Mauricio Santillana
Interface Focus|September 29, 2025
Equity considerations in COVID-19 vaccine allocation modelling: a methodological studyEva Rumpler, Marc Lipsitch
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposureNir Eyal, Marc Lipsitch
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2021
How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is AvailableNir Eyal, Marc Lipsitch
Science (New York, N.Y.)|March 3, 2012
Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypesSarah Cobey, Marc Lipsitch
Epidemiology (Cambridge, Mass.)|June 17, 2008
Too little of a good thing: a paradox of moderate infection controlTed Cohen, Marc Lipsitch
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2020
Opinion: It's ethical to test promising coronavirus vaccines against less-promising onesNir Eyal, Marc Lipsitch
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2025
Focusing a viral risk ranking tool on predictionKatherine Budeski, Marc Lipsitch
NEJM Evidence|May 30, 2024
Diagnostics for Public Health - Infectious Disease Surveillance and ControlMarc Lipsitch, Yonatan Grad
Pageof 45